Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy

AIMS: The aim of this study was to evaluate the low-density lipoprotein cholesterol lowering efficacy and safety of a bempedoic acid 180 mg and ezetimibe 10 mg fixed-dose combination in patients with hypercholesterolemia and a high risk of cardiovascular disease receiving maximally tolerated statin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ballantyne, Christie M, Laufs, Ulrich, Ray, Kausik K, Leiter, Lawrence A, Bays, Harold E, Goldberg, Anne C, Stroes, Erik SG, MacDougall, Diane, Zhao, Xin, Catapano, Alberico L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Drug Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153222/
https://www.ncbi.nlm.nih.gov/pubmed/31357887
http://dx.doi.org/10.1177/2047487319864671

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153222/
https://www.ncbi.nlm.nih.gov/pubmed/31357887
http://dx.doi.org/10.1177/2047487319864671

Ejemplares similares